I. Boll
3 Papers
42 Citations
I. Boll is an academic researcher. The author has contributed to research in topics: Lymphoma & Centroblastic Lymphoma. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Klinische und prognostische Relevanz der Kiel-Klassifikation der Non-Hodgkin-Lymphome
G. Brittinger,H. Bartels,H. Common,Eckhart Dühmke,M. Engelhard,H. H. Fülle,U. Gunzer,T. Gyenes,R. Heinz,König E,P. Meusers,H. Pralle,H. Theml,T. Zwingers,K. Musshoff,A. Stacher,H. Brücher,F. Herrmann,W.-D. Ludwig,W. Pribilla,A. Burger-Schüler,G. W. Löhr,H. Gremmel,J. Oertel,H. Gerhartz,K.-M. Koeppen,I. Boll,Dieter Huhn,T. Binder,A. Schoengen,L. Nowicki,H.W. Pees,P. G. Scheurlen,H. Leopold,M. Wannenmacher,M. Schmidt,Helmut Löffler,G. Michlmayr,Eckhard Thiel,R. Zettel,U. Rühl,H. J. Wilke,E.-W. Schwarze,Hubert J. Stein,Alfred C. Feller,K. Lennert +45 more
TL;DR: Durch die Kiel-Klassifikation wurde eine Neuordnung der Non-Hodgkin-Lymphome in distinkte, auch klinisch-prognostisch differenzier-bare Lymphom-Entitaten erreicht, auf die unabhangig von den bisherigen Therapiestrategien langfristig geringe Beeinflusbarkeit dieser Erkrank
25
Clinical and prognostic heterogeneity of non-Hodgkin lymphomas of high-grade malignancy.
U. Schmalhorst,H. Bartels,I. Boll,A. Burger-Schüler,H. Common,H. H. Fülle,M Graubner,R. Heinz,Dieter Huhn,H. Leopold,Meusers P,L. Nowicki,R Nürnberger,J. Oertel,U. Rühl,G Sieber,M. Schmidt,A. Schoengen,A Strassner,E.-W. Schwarze,Günter Brittinger +20 more
TL;DR: Patients with immunoblastic lymphoma presented more frequently with a reduced performance status and showed a poorer response to radio- and chemotherapy resulting in a worse prognosis discernible after the first year of follow-up.
18
Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
G. Brittinger,Heinrich Bartels,H. Common,E. Dühmke,H. H. Fülle,U. Gunzer,T. Gyenes,R. Heinz,König E,P. Meusers,M. Paukstat,Hans Pralle,H. Theml,Wolfgang Köpcke,C. Thieme,T. Zwingers,K. Musshoff,A. Stacher,H. Brücher,Friedhelm Herrmann,Wolf-Dieter Ludwig,W. Pribilla,A. Burger-Schüler,G. W. Löhr,H. Gremmel,J. Oertel,H. Gerhartz,K.-M. Koeppen,I. Boll,Dieter Huhn,T. Binder,A. Schoengen,L. Nowicki,H.W. Pees,P. G. Scheurlen,H. Leopold,M. Wannenmacher,M. Schmidt,H. Löffler,G. Michlmayr,Eckhard Thiel,R. Zettel,U. Rühl,H. J. Wilke,E.-W. Schwarze,Harald Stein,A. C. Feller,Karl Lennert +47 more
TL;DR: Investigation of the Kiel classification of non‐Hodgkin lymphomas found marked improvement of prognosis was solely possible by induction of complete remissions whereas in corresponding low‐grade malignant lymphomas also partial remissions were prognostically relevant.